Literature DB >> 376446

Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero.

R N Cahill, D C Poskitt, I Heron, Z Trnka.   

Abstract

Techniques for establishing chronic lymphatic fistulae in the intestinal and prescapular lymphatic ducts of fetal lambs during the test third of gestation are described. Despite the absence of antibody, immunoglobulin and extrinsic antigen, the number of recirculating lymphocytes increases considerably through gestation. Both thymus-derived and surface Ig-bearing B lymphocytes are present in the fetal recirculating pool and they appear to increase in number at the same rate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376446     DOI: 10.1159/000232248

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Recirculation of lymphocyte subsets (CD5+, CD4+, CD8+, T19+ and B cells) through fetal lymph nodes.

Authors:  W G Kimpton; E A Washington; R N Cahill
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

2.  Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80.

Authors:  M Miyasaka; I Heron; L Dudler; R N Cahill; L Forni; T Knaak; Z Trnka
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

3.  Late-term fetal thymectomy does not prevent the development of gut-homing T cells after birth.

Authors:  R N Cahill; W G Kimpton; E A Washington; L Dudler; Z Trnka
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes.

Authors:  M D Gorrell; M R Brandon; D Sheffer; R J Adams; O Narayan
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Traffic and proliferative responses of recirculating lymphocytes in fetal calves.

Authors:  W R Hein; J N Shelton; M W Simpson-Morgan; B Morris
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.